ÂÜÀòÂÒÂ×

Phil Marchand

Member, Scientific Advisory Board at Cellular Logistics

Phil is a medtech engineer with 25 years of experience in the field, specializing in product development of disruptive technologies from concept to commercialization. He was one of the earlier pioneers in Trans Aortic Valve Replacement, responsible for the RetrofleX™ catheter delivery system. He invented and developed the WEB™ Aneurysm Embolic system at Sequent medical which was acquired by Terumo and developed the ClotTriever™ at Inari Medical. Most recently, at BlueRock Therapeutics, he was responsible for all drug delivery aspects from device to cell delivery matrix. Phil holds a Bachelor’s and Master’s degree in Biosystems Engineering from McGill University in Montreal.


Org chart

This person is not in the org chart